Serum IL-17 after one course of sublingual immunotherapy in allergic rhinitis to birch

Giorgio Ciprandi, D. Fenoglio, M. De Amici, G. Marseglia, G. Murdaca, M. Di Gioacchino

Research output: Contribution to journalArticlepeer-review

Abstract

Recently, it has been reported that IL-17 may be involved in allergic reaction. Sublingual immunotherapy (SLIT) is the unique curative treatment for allergic rhinitis. This study aims at investigating whether one course of birch SLIT could affect serum IL-17 levels. The findings provided show that some IL-17 producer patients had a reduction of serum IL-17 levels after one SLIT course. Therefore, this preliminary study shows that a single pre-seasonal SLIT course may induce a significant decreasing trend in serum IL-17 levels; further study should be carried out to define the role exerted by IL-17 in allergic rhinitis.

Original languageEnglish
Pages (from-to)49-51
Number of pages3
JournalEuropean Journal of Inflammation
Volume7
Issue number1
Publication statusPublished - Jan 2009

Keywords

  • Allergic rhinitis
  • IL-17
  • Sublingual immunotherapy

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Fingerprint Dive into the research topics of 'Serum IL-17 after one course of sublingual immunotherapy in allergic rhinitis to birch'. Together they form a unique fingerprint.

Cite this